MedPath

Assessment of Marginal Bone Loss and Anterior Implant Stability in Immediate Versus Early Implant Placement

Not Applicable
Completed
Conditions
Marginal Bone Loss
Registration Number
NCT06985511
Lead Sponsor
Yasser Ahmed
Brief Summary

This study aims to determine the differences in implant stability and measurement of bone loss near implants between two different healing approaches used for teeth replacement in the front part of the upper jaw.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • Presence of unrestorable bilateral anterior teeth.
  • Harmonious gingival contour and thick gingival phenotype
  • Minimum 4 mm of apical bone and 2 mm of intact labial plate
  • Absence of periapical pathology
Exclusion Criteria
  • Systemic conditions affecting osseointegration or healing
  • Active oral infections or periodontal disease
  • Dehiscence or fenestration defects
  • Poor oral hygiene or heavy smoking

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Implant stabilityup to 12 months

Implant Stability Quotient (ISQ) values were measured using Osstell. To ensure accuracy, the probe was positioned at a 90° angle and 3 mm above soft tissue level, as recommended in previous protocols. Osstell's patented technology uses the ISQ scale, with values ranging from 1 to 100, where higher values indicate greater stability

Marginal Bone Lossup to 12 months

Cone beam computed tomography (CBCT) scans were obtained at the time of final restoration and post-placement. Measurements were made (in mm) from the implant platform to the most coronal bone level using OnDemand3D software. Each scan was oriented to align the implant with the axial plane. Measurements were performed by a single calibrated examiner to a precision of 0.01 mm.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Beirut Arab University

🇱🇧

Beirut, Lebanon

Beirut Arab University
🇱🇧Beirut, Lebanon

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.